Top Markets
Coin of the day
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
株式のランク #20647
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
株価
$0.517
最終同期: 2026-08-21
時価総額
$125.14M
変化(1日)
-0.58%
変化(1年)
47.71%
US
取引 Vaxart, Inc. (VXRT)

カテゴリー

Vaxart, Inc.(VXRT)の株価履歴
終値の最高値: $0.54 (2026-08-01)

終値の最安値: $93.11 (1981-12-01)
Vaxart, Inc. の株価履歴(1981 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 46.78%
2025 -40.84%
2024 -5.29%
2023 -36.66%
2022 -84.42%
2021 -8.81%
2020 2,164.33%
2019 -87.67%
2018 -59.95%
2017 -54.04%
2016 -35.58%
2015 -12.95%
2014 -44.23%
2013 -0.82%
2012 -63.27%
2011 -66.84%
2010 11.78%
2009 44.58%
2008 -4.77%
2007 -47.85%
2006 98.68%
2005 -76.37%
2004 32.53%
2003 72.81%
2002 -34.23%
2001 142.99%
2000 -8.21%
1999 63.47%
1998 -25.43%
1997 -61.94%
1996 -1.29%
1995 40.51%
1994 119.96%
1993 5.65%
1992 -17.87%
1991 266.03%
1990 29.50%
1989 -17.75%
1988 0.26%
1987 -37.28%
1986 45.28%
1985 11.99%
1984 -51.20%
1983 6.47%
1982 23.65%
1981 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.26 -15.20%
AU
$770.19 8.98%
CH